Principal Investigator
Peter Hosein
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20240878
Clinical Trial Summary
A Phase 3 Multicenter, Open-label, Randomized
Study of RMC-6236 versus Investigator’s Choice of Standard of
Care Therapy in Patients with Previously Treated Metastatic
Pancreatic Ductal Adenocarcinoma (PDAC)
Phase
Phase III
Funding Agency/Sponsor
Industrial
Disease
Pancreatic, Liver, and Related Cancers
Contact Information
Phone Number
305-243-2647